Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy

Leukemia

Volumn 14, Issue 4, 2000, Pages 688-695

  Van Lochem, E G ^a   Wiegers, Y M ^a   Van Den Beemd, R ^a   Hahlen K ^a   Van Dongen, J J M ^a   Hooijkaas, H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute lymphoblastic leukemia; Bone marrow; Flow cytometry; Immunophenotyping; Precursor B cells; Regeneration

Indexed keywords

ASPARAGINASE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; DEXAMETHASONE; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER REGRESSION; CELL MATURATION; CELL REGENERATION; CELL STRUCTURE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; PRE B LYMPHOCYTE; PRIORITY JOURNAL; STEM CELL;

EID: 0034037006     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401749     Document Type: Article

References (30)

1. Van Dongen JJM, Adriaansen HJ. Immunobiology of leukemia. In: Henderson ES, Lister TA, Greaves MF (eds). Leukemia, 6th edn. WB Saunders: Philadelphia, 1996, pp 83-130.
2. Visser O, Coebergh JWW, Schouten JL, Dijck JAAM van (eds). Incidence of Cancer in the Netherlands 1995. Seventh report of the Netherlands Cancer Registry. Vereniging van Integrale Kankercentra: Utrecht, 1998.
3. Pui CH. Childhood leukemias. New Engl J Med 1998; 339: 605-614.
4. Van Dongen JJM, Hooijkaas H, Adriaansen HJ, Hählen K, Van Zanen CE. Detection of minimal residual acute lymphoblastic leukemia by immunological marker analysis: possibilities and limitations. In: A Hagenbeek, B Löwenberg (eds). Minimal Residual Disease in Acute Leukemia. M Nijhoff: Dordrecht, 1986, pp 113-133.
5. Van Dongen JJM, Breit TM, Adriaansen HJ, Beishuizen A, Hooijkaas H. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 6: 47-59.
6. Campana D, Pui C-H. Detection of minimal residual disease in acute leukemia: methodological advances and clinical significance. Blood 1995; 85: 1416-1434.
7. Van Dongen JJM, Szczepanski T, De Bruijn MAC, Van den Beemd MWM, De Bruin-Versteeg S, Wijkhuijs JM, Tibbe GJM, Van Gastel-Mol EJ, Groeneveld K, Hooijkaas H. Detection of minimal residual disease in acute leukemia patients. Cytokin Mol Ther 1996 2: 121-133.
8. Janossy G, Bollum FJ, Bradstock KF, Ashley J. Cellular phenotypes of normal and leukemic hemopoietic cells determined by analysis with selected antibody combinations. Blood 1980; 56: 430-441.
9. Knulst AC, Adriaansen HJ, Hählen K, Stigter JC, Van den Beemd MWM, Hagemeijer A, Van Dongen JJM, Hooijkaas H. Early diagnosis of smoldering acute lymphoblastic leukemia using immunological marker analysis. Leukemia 1993; 7: 532-536.
10. Ryan D, Kossover S, Mitchell S, Frantz C, Hennessy L, Cohen H. Subpopulations of common acute lymphoblastic leukemia antigen-positive lymphoid cells in normal bone marrow identified by hematopoietic differentiation antigens. Blood 1986; 68: 417-425.
11. Lucio P, Parreira A, van den Beemd MWM, van Lochem EG, van Wering ER, Baars E, Porwit-MacDonald A, Bjorklund E, Gaipa G, Biondi A, Orfao A, van Dongen JJM, San Miguel JF. Flow cytometric analysis of normal and leukemic bone marrow B-cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL patients. Part I. Normal B cell differentiation. Leukemia 1999; 13: 419-427.
12. Kluin-Nelemans HC, Bolhuis RL, Löwenberg B, Campana D, Sizoo W. Characterization of normal and regenerating bone marrow cells with a panel of monoclonal antibodies. Scand J Haematol 1986; 36: 71-78.
13. Van den Doel LJ, Pieters R, Huismans DR, Van Zantwijk CH, Loonen AH, Broekema GJ, de Waal FC, Veerman AJP. Immunological phenotype of lymphoid cells in regenerating bone marrow of children after treatment for acute lymphoblastic leukemia. Eur J Haematol 1988; 41: 170-175.
14. +, pre-B, and B cells in bone marrow after allogeneic bone marrow transplantation. Transplantation 1987; 43: 865-870.
15. + and double-positive cells in the bone marrow and blood after autologous bone marrow transplantation. Eur J Haematol 1991; 46: 146-151.
16. Farahat N, Lens D, Zomas A, Morilla R, Matutes E, Catovsky D. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursor. Br J Haematol 1995; 91: 640-646.
17. Lavabre-Bertrand T, Janossy G, Ivory K, Peters R, Secker-Walker L, Porwit-MacDonald A. Leukemia-associated changes identified by quantitative flow-cytometry: I CD10 expression. Cytometry 1994; 18: 209-217.
18. Veerman AJP, Hählen K, van Leeuwen EF, De Vaan GAM, Solbu G, Siciu S, Van Wering E, Van der Does-Van den Berg A. High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol 1996; 14: 911-918.
19. Reiter A, Schrappe M, Ludwig WD, Hiddemann W, Sauter S, Henze G, Zimmermann M, Lampert F, Havers W, Niethammer D, Odenwald E, Ritter J, Mann G, Welte K, Gadner H, Riehm H. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-3133.
20. Van Dongen-Melman IEWM, de Groot A, van Dongen JJM, Verhulst FC, Hählen K. Cranial irradiation is the major cause of learning problems in children treated for leukemia and lymphoma: a comparative study. Leukemia 1997; 11: 1197-1200.
21. Van Dongen JJM, Hooijkaas H, Comans-Bitter M, Hählen K, De Klein A, Van Zanen GE, Van 't Veer MB, Abels I, Benner R. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes. J Immunol 1985; 135: 3144-3150.
22. Groeneveld K, Te Marvelde JG, Van den Beemd MWM, Hooijkaas H, Van Dongen JJM. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Leukemia 1996; 10: 1383-1389.
23. Van Lochem EG, Groeneveld K, Te Marvelde JG, Van den Beemd MWM, Hooijkaas H, Van Dongen JJM. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes. Testing of a new fixation-permeabilization solution. Leukemia 1997; 11: 2208-2210.
24. Ryan DH, Van Dongen JJM. Detection of residual disease in acute leukemia using immunological markers. In: Bennett JM, Foon KA (eds). Immunologic Approaches to the Classification and Management of Lymphomas and Leukemias. Kluwer Academic: Norwell, MA, 1988, pp 173-207.
25. San Miguel JF, Orfao A, Pongers-Willemse MJ, Van Dongen JJM. Detection of minimal residual disease in acute lymphoblastic leukemia. In: Willemze R, McArthur JR, Kansu E (eds). Educational Program Book 1998 of ISH-EHA Combined Haematology Congress. EHA: Amsterdam, 1998, pp 22-29.
26. Dworzak MN, Fritsch G, Fleischer C, Printz D, Fröschl G, Buchinger P, Mann G, Gadner H. Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow. Leukemia 1997; 11: 1266-1273.
27. Beishuizen A, Verhoeven MA, Mol EJ, Breit TM, Wolvers-Tettero IL, Van Dongen JJM. Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia 1993; 7: 2045-2053.
28. Langerak AW, Szczepanski T, Van der Burg M, Wolvers-Tetteroo IL, Van Dongen JJM. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997; 11: 2192-2199.
29. Szczepanski T, Langerak AW, Wolvers-Tettero ILM, Ossenkoppele GJ, Verhoef G, Stul M, Petersen EJ, De Bruijn MAC, Van 't Veer MB, Van Dongen JJM. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease. Leukemia 1998; 12: 1081-1088.
30. Morley AA, Brisco MJ, Rice M, Snell E, Peng LM, Hughes E, Neoh SH, Sykes PJ. Leukaemia presenting as marrow hypoplasia: molecular detection of the leukaemic clone at the time of initial presentation. Br J Haematol 1997; 98: 940-944.